SOURCE: Ingen Technologies Inc.

Ingen Technologies Inc.

July 10, 2012 09:12 ET

Ingen Continues With Preparations for a National Distribution Program

32 Million COPD Patients Now Have Easier Access to Ingen's OxyView® Products

RIVERSIDE, CA--(Marketwire - Jul 10, 2012) - Ingen Technologies, Inc. (PINKSHEETS: IGNT), an emerging medical device manufacturer with proprietary products for the growing $4B respiratory markets, announced today that the company is moving forward with a leading national medical supplier for the home healthcare and hospital markets. As previously mentioned in an earlier press release an announcement will be made at the proper time in the near future.

In order to keep our financial information current with the OTC Pinksheets, we plan on issuing our unaudited annual report ending May 31st, 2012 later this week. This will give investors a true picture of our current financial position. "We are working hard to bring our shareholders straightforward and up to date information so they are able to make informed and intelligent decisions," stated Gary Tilden, Chairman and COO of Ingen Technologies, Inc.

FOR MORE UPDATED INFORMATION USE THE FOLLOWING LINK: www.otcfn.com/ignt/

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

Contact Information